Cell Pathways to Present At The Wall Street Analyst Forum's Conference.

Business Editors & Health/Medical Writers

BIOWIRE2K

The Wall Street Analyst Forum's Conference

HORSHAM, Pa.----(BW HealthWire)--Feb. 8, 2002

Cell Pathways, Inc. (Nasdaq:CLPA) today announced that Robert J. Towarnicki, chairman and chief executive officer, and Dr. Rifat Pamukcu, chief scientific officer, will present an overview of the company at The Wall Street Analyst Forum's 43rd Institutional Investor Conference. The presentation will be delivered at 10:50 a.m. (EST) on Tuesday, Feb. 12, 2002 at The Roosevelt Hotel in New York and will be accessible online live and archived for replay for 30 days in the investor relations section of the company's web site at www.cellpathways.com.

"We look forward to presenting an overview of Cell Pathways' progress and plans to the healthcare investors at The Wall Street Forum's Institutional Investor Conference," said Towarnicki. "We hope that investors not attending the Forum take advantage of the opportunity to participate in the conference via the webcast."

Cell Pathways, Inc., headquartered in Horsham, Pa., is a development stage pharmaceutical company focused on the research, development and commercialization of novel and unique medications to prevent and treat cancer. For additional information on Cell Pathways, Inc., visit the company's web site at www.cellpathways.com.

Certain statements made herein, and oral statements made in respect hereof, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are those which express plan, anticipation, intent, contingency or future development and/or otherwise are not statements of historical fact. These statements are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. These risks are detailed in the Company's reports filed from time to time under the Securities Act of 1933 and/or the Securities Exchange Act of 1934. You are encouraged to read these filings as they are made. They are available over the Internet from the SEC in its EDGAR database. Investors are cautioned not to place undue reliance on any such forward-looking statements, any of which may turn out to be wrong due to inaccurate assumptions, unknown risks, uncertainties or other factors. No forward-looking statement can be guaranteed; actual future results may vary materially. Both forward-looking statements and statements of historic fact must be understood in the context of the risks referred to above which characterize the Company's development stage business. The Company undertakes no obligation to update or revise the statements made herein or the factors which may relate thereto.